Shanpeng Li

529 total citations
15 papers, 241 citations indexed

About

Shanpeng Li is a scholar working on Genetics, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shanpeng Li has authored 15 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Genetics and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shanpeng Li's work include BRCA gene mutations in cancer (3 papers), Glioma Diagnosis and Treatment (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Shanpeng Li is often cited by papers focused on BRCA gene mutations in cancer (3 papers), Glioma Diagnosis and Treatment (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Shanpeng Li collaborates with scholars based in United States, Switzerland and China. Shanpeng Li's co-authors include María Valero‐Muñoz, Flora Sam, Richard Wilson, Marc Iglarz, Jiyoon Kim, Michael W. Yeh, Masha J. Livhits, Chi‐Hong Tseng, José J. Fuster and Matthias Nahrendorf and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Shanpeng Li

12 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanpeng Li United States 6 106 72 37 36 33 15 241
Shengda Hu China 11 90 0.8× 25 0.3× 30 0.8× 81 2.3× 41 1.2× 17 296
Rose Snipes United States 7 125 1.2× 86 1.2× 24 0.6× 37 1.0× 34 1.0× 9 318
Hiroshi Sugino Japan 6 215 2.0× 98 1.4× 34 0.9× 163 4.5× 19 0.6× 18 373
Feiming Ye China 10 107 1.0× 26 0.4× 18 0.5× 83 2.3× 19 0.6× 12 277
Kristine M. Morin United States 4 77 0.7× 21 0.3× 51 1.4× 58 1.6× 25 0.8× 4 274
G. Pfliegler Hungary 12 100 0.9× 59 0.8× 15 0.4× 43 1.2× 16 0.5× 21 329
А.В. Сотников Russia 5 35 0.3× 29 0.4× 71 1.9× 77 2.1× 42 1.3× 45 234
Astin S. Powers United States 7 36 0.3× 22 0.3× 46 1.2× 57 1.6× 109 3.3× 15 273
Anne-Cécile Huby France 7 91 0.9× 29 0.4× 15 0.4× 99 2.8× 10 0.3× 14 243
Jan Schovánek Czechia 11 36 0.3× 140 1.9× 27 0.7× 51 1.4× 14 0.4× 32 298

Countries citing papers authored by Shanpeng Li

Since Specialization
Citations

This map shows the geographic impact of Shanpeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanpeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanpeng Li more than expected).

Fields of papers citing papers by Shanpeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanpeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanpeng Li. The network helps show where Shanpeng Li may publish in the future.

Co-authorship network of co-authors of Shanpeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shanpeng Li. A scholar is included among the top collaborators of Shanpeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanpeng Li. Shanpeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ellingson, Benjamin M., Robert Chong, Ida Sonni, et al.. (2025). A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neuro-Oncology Advances. 7(1). vdaf022–vdaf022.
2.
Li, Shanpeng, Michelle Afkhami, Jasmine Zain, et al.. (2025). T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell Lymphoma. JAMA Dermatology. 162(1). 8–8.
3.
Ngo, Dat, Shanpeng Li, Joycelynne Palmer, et al.. (2024). Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leukemia & lymphoma. 65(3). 372–377. 2 indexed citations
4.
5.
Ellingson, Benjamin M., Patrick Y. Wen, Susan M. Chang, et al.. (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology. 25(6). 1017–1028. 25 indexed citations
6.
Kim, Na Eun, Chi‐Hong Tseng, Shanpeng Li, et al.. (2023). Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3. The Journal of Clinical Endocrinology & Metabolism. 108(9). e698–e703. 17 indexed citations
7.
Sun, Lu, Jenny C. Kienzler, Alex Lee, et al.. (2023). Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors. Journal of Clinical Investigation. 133(17). 18 indexed citations
8.
Li, Shanpeng, Chi‐Hong Tseng, Jianyu Rao, et al.. (2023). Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hürthle cell cytology. Surgery. 175(1). 221–227. 4 indexed citations
9.
Chin, Arnold I., Alexandra Drakaki, Sara Rodríguez, et al.. (2022). Interim results of a phase Ib single-center study of pembrolizumab in combination with chemotherapy in patients with locally advanced or metastatic small cell/neuroendocrine cancers of the prostate and urothelium.. Journal of Clinical Oncology. 40(6_suppl). 510–510. 1 indexed citations
10.
Li, Shanpeng, Ning Li, Hong Wang, et al.. (2022). Efficient Algorithms and Implementation of a Semiparametric Joint Model for Longitudinal and Competing Risk Data: With Applications to Massive Biobank Data. Computational and Mathematical Methods in Medicine. 2022. 1–12. 4 indexed citations
11.
Wang, Hong, Ning Li, Shanpeng Li, & Gang Li. (2021). JMcmprsk: An R Package for Joint Modelling of Longitudinal and Survival Data with Competing Risks. The R Journal. 13(1). 53–53. 3 indexed citations
12.
13.
Li, Shanpeng, Chi‐Hong Tseng, Jiyoon Kim, et al.. (2020). Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017. The Journal of Clinical Endocrinology & Metabolism. 105(6). 1770–1777. 46 indexed citations
14.
Valero‐Muñoz, María, et al.. (2016). Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction. Circulation Heart Failure. 9(11). 62 indexed citations
15.
Valero‐Muñoz, María, Shanpeng Li, Richard Wilson, et al.. (2016). Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue. Circulation Heart Failure. 9(1). e002724–e002724. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengda Hu Breakdown of academic impact, for papers by Rose Snipes Breakdown of academic impact, for papers by Hiroshi Sugino Breakdown of academic impact, for papers by Feiming Ye Breakdown of academic impact, for papers by Kristine M. Morin Breakdown of academic impact, for papers by G. Pfliegler Breakdown of academic impact, for papers by А.В. Сотников Breakdown of academic impact, for papers by Astin S. Powers Breakdown of academic impact, for papers by Anne-Cécile Huby Breakdown of academic impact, for papers by Jan Schovánek
Rankless by CCL
2026